Valneva SE (VALN) Change in Taxes (2021 - 2026)
Valneva SE (VALN) posted Change in Taxes of -$1170.7 for Q1 2026, up 99.93% sequentially from -$1.7 million in Q3 2025, and up 99.73% YoY from -$586.17 in Q1 2025.
Valneva SE (VALN) Change in Taxes (2021 - 2026) Analysis & Trends
Valneva SE has reported Change in Taxes for 6 years, with the latest figure at -$1170.7 in Q1 2026.
- Quarterly Change in Taxes rose 99.73% year-over-year to -$1170.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 20.33% YoY) and the FY2024 annual result came in at -$1.7 million, down 25.07% from the prior year.
- Change in Taxes grew to -$1170.7 in Q1 2026 per VALN's latest filing, from -$1.7 million in the prior quarter.
- Over five years, Change in Taxes peaked at $699.0 million in Q3 2023 and troughed at -$699.7 million in Q2 2023.
- A 5-year average of -$362552.2 and a median of -$352216.0 in 2022 frame the typical range for Change in Taxes.
- The widest YoY moves for Change in Taxes: up 262688.54% in 2023, down 131047.09% in 2023.
- Over 5 years, Change in Taxes stood at $946789.6 in 2022, then slumped by 136.71% to -$347528.6 in 2023, then surged by 104.0% to $13891.7 in 2024, then tumbled by 12681.13% to -$1.7 million in 2025, then surged by 99.93% to -$1170.7 in 2026.
- According to Business Quant data, Change in Taxes over the past three periods registered -$1170.7, -$1.7 million, and -$185641.4 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,170.75 |
| Mar 31, 2026 | -1,170.75 |
| Sep 30, 2025 | -1.75 Mn |
| Sep 30, 2025 | -1.75 Mn |
| Jun 30, 2025 | -185,641.39 |
| Jun 30, 2025 | -185,641.39 |
| Mar 31, 2025 | -432,324.50 |
| Mar 31, 2025 | -432,324.50 |
| Dec 31, 2024 | 13,891.74 |
| Dec 31, 2024 | 13,891.74 |
| Sep 30, 2024 | -496,395.22 |
| Sep 30, 2024 | -496,395.22 |
| Jun 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.05 Mn |
| Mar 31, 2024 | -140,140.67 |
| Mar 31, 2024 | -140,140.67 |
| Dec 31, 2023 | -347,528.59 |
| Dec 31, 2023 | -347,528.59 |
| Sep 30, 2023 | 698.97 Mn |
| Sep 30, 2023 | 698.97 Mn |